Evotec SE (EVO) Equity Income (2009 - 2023)
Evotec SE's (EVO) quarterly Equity Income came in at $7.8 million in Q3 2023, up 276.08% quarter-over-quarter from -$4.4 million in Q2 2023.
Analysis
Evotec SE (EVO) Equity Income (2009 - 2023) Analysis & Trends
Evotec SE has disclosed Equity Income across 3 years of filings, most recently posting $7.8 million for Q3 2023.
- In Q3 2023, Equity Income changed N/A year-over-year to $7.8 million; the TTM figure through Aug 2023 stood at $14.8 million (changed N/A YoY), while the FY2022 annual figure was $8.0 million, changed N/A from the prior year.
- Equity Income came in at $7.8 million for Q3 2023 at Evotec SE, up from -$4.4 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of $7.8 million in Q3 2023 to a low of -$4.4 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 17.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | - |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -4.67 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 29, 2023 | 7.78 Mn |
| Jun 30, 2023 | -4.42 Mn |
| Dec 31, 2022 | 7.78 Mn |
| Sep 30, 2022 | 3.64 Mn |
| Jun 30, 2022 | -4.37 Mn |
| Dec 31, 2009 | -826,971.17 |
| Jun 30, 2009 | -62,635.82 |
| Mar 31, 2009 | 19,616.00 |